ORIGINAL RESEARCH article
Front. Physiol.
Sec. Environmental, Aviation and Space Physiology
Volume 16 - 2025 | doi: 10.3389/fphys.2025.1645475
This article is part of the Research TopicBioconvergence: A New Frontier for Understanding and Enhancing Human Adaptations to Extreme EnvironmentsView all articles
The Thermogenic Effect of Mirabegron Ingestion during Cool Conditions
Provisionally accepted- 1Indiana University Bloomington, Bloomington, United States
- 2Indiana University Health, Bloomington, United States
- 3Colorado State University, Fort Collins, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Brown adipose tissue (BAT) is highly thermogenic and can be stimulated by cold exposure or mirabegron, a β3-adrenergic receptor agonist. However, it is currently not known whether the thermogenic effects of mirabegron are observed during exposure to cool temperatures. We tested the hypotheses that energy expenditure and BAT activation would be greater following mirabegron ingestion versus a placebo (PLA). Eleven healthy adults (5 women) completed four, double-blind, randomized visits to the laboratory involving the acute ingestion of 100 mg, 150 mg, and 200 mg of mirabegron or PLA. Following ingestion, subjects rested for 6 h in a wholebody indirect room calorimeter (20°C, 50% RH). Cumulative energy expenditure was calculated for each study visit. Using infrared thermography, supraclavicular BAT activity was assessed via the area under the curve (AUC) for supraclavicular skin temperature (Tsc) expressed relative to sternal skin temperature for each visit. Cumulative energy expenditure was greater following ingestion of 100 mg (494 ± 75 kcal; p < 0.001), 150 mg (481 ± 67 kcal; p = 0.017), and 200 mg (492 ± 69 kcal; p = 0.001) of mirabegron vs. PLA (456 ± 67 kcal), with no differences between doses (p > 0.05). The AUC for Tsc was greater following ingestion of 100 mg (12.54 ± 7.51°C x min; p = 0.011) and 150 mg (10.01 ± 6.05°C x min; p = 0.021) doses of mirabegron vs. PLA (4.74 ± 3.86°C x min), but not the 200 mg dose (9.17 ± 5.95°C x min; p = 0.067). Our data indicate β3-adrenergic receptor activation of supraclavicular BAT via mirabegron ingestion enhances thermogenesis in cool environments.
Keywords: cold exposure, Brown adipose tissue (BAT), beta-3 adrenergic receptor agonist, Infrared thermograhy, Mirabegron
Received: 11 Jun 2025; Accepted: 06 Aug 2025.
Copyright: © 2025 Gorini Pereira, Ryan, Miller, Watters, Mickleborough, Schlader, Bell and Johnson. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Felipe Gorini Pereira, Indiana University Bloomington, Bloomington, United States
Zachary J Schlader, Indiana University Bloomington, Bloomington, United States
Blair D Johnson, Indiana University Bloomington, Bloomington, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.